1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Demographic characteristics and epilepsy features of the TLE and control groups*
Characteristics TLE (n = 21) Controls (n = 21) Age (yr) 37.3 (10.0) 33.0 (10.2) Education 13.2** (2.2) 16.5 (2.3) Sex (females-males) 11:10 11:10 Age of seizure onset (yr) 14.3 (11.5) – Duration of illness (yr) 23.0 (14.6) – Seizure frequency (per month) 6.7 (7.4) –
Note:— – indicates not applicable; TLE, temporal lobe epilepsy.
* SDs are in parentheses.
** Group mean is statistically different from that of controls at P < .05.